How androgens exert their anabolic effects. Interaction of testosterone and growth hormone at the hepatic level.
How androgens exert their anabolic effects: Interaction of testosterone and growth hormone at the hepatic level in men with hypogonadism or hypopituitarism.
Department of Endocrinology, St Vincents Hospital Sydney
36 participants
Jun 1, 2005
Interventional
Conditions
Summary
Observations from previous studies suggest that the full action of GH requires the presence of male hormones like Testosterone (T). We will test the hypothesis that T enhances GH effect acting on the liver. We will compare the body protein production after delivering T exclusively to the liver (capsules) and to peripheral tissues (patch). The first phase (11 weeks, 6 visits) aims to find the T dose which exposes the liver to normal/physiological T levels. The second phase (16 weeks, 5 visits) will compare the effect of delivering T to the liver and to peripheral tissues.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
oral micronised testosterone 5 - 40 mg daily for 2 - 5 periods of 14 days. transdermal testosterone (Androderm) 5mg daily for 1 -3 periods of 14 days. recominant human growth hormone (GH)(Humatrope) 0.5 mg daily for 18 weeks (GH deficient subjects only!)
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000482662